首站-论文投稿智能助手
典型文献
Interferon-gamma inhibits aldehyde dehydrogenase bright cancer stem cells in the 4T1 mouse model of breast cancer
文献摘要:
Background::Despite improvements in disease diagnosis, treatment, and prognosis, breast cancer is still a leading cause of cancer death for women. Compelling evidence suggests that targeting cancer stem cells (CSCs) have a crucial impact on overcoming the current shortcomings of chemotherapy and radiotherapy. In the present study, we aimed to study the effects of T cells and a critical anti-tumor cytokine, interferon-gamma (IFN-γ), on breast cancer stem cells.Methods::BALB/c mice and BALB/c nude mice were subcutaneously injected with 4T1 tumor cells. Tumor growth and pulmonary metastasis were assessed. ALDEFLOUR TM assays were performed to identify aldehyde dehydrogenase bright (ALDH br) tumor cells. ALDH br cells as well as T cells from tumor-bearing BALB/c mice were analyzed using flow cytometry. The effects of CD8 + T cells on ALDH br tumor cells were assessed in vitro and in vivo. The expression profiles of ALDH br and ALDH dim 4T1 tumor cells were determined. The levels of plasma IFN-γ were measured by enzyme-linked immunosorbent assay, and their associations with the percentages of ALDH br tumor cells were evaluated. The effects of IFN-γ on ALDH expression and the malignancy of 4T1 tumor cells were analyzed in vitro. Results::There were fewer metastatic nodules in tumor-bearing BALB/c mice than those in tumor-bearing BALB/c nude mice (25.40 vs. 54.67, P < 0.050). CD8 + T cells decreased the percentages of ALDH br 4T1 tumor cells in vitro (control vs. effector to target ratio of 1:1, 10.15% vs. 5.76%, P < 0.050) and in vivo (control vs. CD8 + T cell depletion, 10.15% vs. 21.75%, P < 0.001). The functions of upregulated genes in ALDH br 4T1 tumor cells were enriched in the pathway of response to IFN-γ. The levels of plasma IFN-γ decreased gradually in tumor-bearing BALB/c mice, while the percentages of ALDH br tumor cells in primary tumors increased. IFN-γ at a concentration of 26.68 ng/mL decreased the percentages of ALDH br 4T1 tumor cells (22.88% vs. 9.88%, P < 0.050) and the protein levels of aldehyde dehydrogenase 1 family member A1 in 4T1 tumor cells (0.86 vs. 0.49, P < 0.050) and inhibited the abilities of sphere formation (sphere diameter <200 μm, 159.50 vs. 72.0; ≥200 μm, 127.0 vs. 59.0; both P < 0.050) and invasion (89.67 vs. 67.67, P < 0.001) of 4T1 tumor cells. Conclusion::CD8 + T cells and IFN-γ decreased CSC numbers in a 4T1 mouse model of breast cancer. The application of IFN-γ may be a potential strategy for reducing CSCs in breast cancer.
文献关键词:
Cancer stem cells;Aldehyde dehydrogenase;Interferon-gamma;CD8 + T cells
作者姓名:
Zhuang Xiufen;Shi Guilan;Hu Xiao;Wang Huiru;Sun Wen;Wu Yanhong
作者机构:
Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212000, China;Department of Immunology, Zibo Vocational Institute Health School, Zibo, Shandong 255000, China;Department of Medical Engineering, Morsani College of Medicine, Tampa, FL 33612, USA;Department of Oncology, Suqian First Hospital, Suqian, Jiangsu 223800, China;Department of Blood Transfusion, The First Affiliated Hospital of USTC, Hefei, Anhui 230001, China;Department of Medical Microbiology and Immunology, School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui 241002, China
引用格式:
[1]Zhuang Xiufen;Shi Guilan;Hu Xiao;Wang Huiru;Sun Wen;Wu Yanhong-.Interferon-gamma inhibits aldehyde dehydrogenase bright cancer stem cells in the 4T1 mouse model of breast cancer )[J].中华医学杂志(英文版),2022(02):194-204
A类:
dehydrogenase ,cancer ,ALDEFLOUR ,ALDH ,analyzed ,Aldehyde,cells
B类:
Interferon,gamma,inhibits,aldehyde,bright,stem,4T1,mouse,model,breast,Background,Despite,improvements,disease,diagnosis,treatment,prognosis,still,leading,cause,death,women,Compelling,evidence,suggests,that,targeting,CSCs,have,crucial,impact,overcoming,current,shortcomings,chemotherapy,radiotherapy,present,study,aimed,effects,critical,anti,cytokine,interferon,IFN,Methods,BALB,mice,nude,were,subcutaneously,injected,Tumor,growth,pulmonary,metastasis,assessed,TM,assays,performed,identify,well,from,bearing,using,flow,cytometry,CD8 ,vitro,vivo,expression,profiles,dim,determined,levels,plasma,measured,by,enzyme,linked,immunosorbent,their,associations,percentages,evaluated,malignancy,Results,There,fewer,metastatic,nodules,than,those,decreased,control,effector,depletion,functions,upregulated,genes,enriched,pathway,response,gradually,while,primary,tumors,increased,concentration,protein,family,member,A1,inhibited,abilities,sphere,formation,diameter,both,invasion,Conclusion,numbers,application,may,potential,strategy,reducing,Cancer
AB值:
0.368648
相似文献
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Therapeutic effects of the extract of Sancao Formula,a Chinese herbal compound,on imiquimod-induced psoriasis via cysteine-rich protein 61
Wan-jun Guo;Yi Wang;Yu Deng;Lin-yan Cheng;Xin Liu;Ruo-fan Xi;Sheng-jie Zhu;Xin-yi Feng;Liang Hua;Kan Ze;Jian-yong Zhu;Dong-jie Guo;Fu-lun Li-Department of Dermatology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China;School of Medicine,Chengdu University,Chengdu 610106,Sichuan Province,China;Institute of Cancer Biology and Drug Discovery,Chengdu University,Chengdu 610106,Sichuan Province,China;Clinical Laboratory Medicine Center,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。